🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to learn if people who receive intismeran autogen...
Status
Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0181)
Start Date
2024-10-21
Trial ID
NCT06623422
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of pembro...
Status
Completed
Location
Southern Cancer Center, PC
Start Date
2018-01-09
Trial ID
NCT03322566
Treatments Being Tested
The purpose of this study is to determine whether TH-302 in combination wit...
Status
Terminated
Location
UAB Cancer Center
Start Date
2014-06
Trial ID
NCT02093962
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and pharmaco...
Status
Completed
Location
UCLA
Start Date
2020-12-15
Trial ID
NCT04619797
This is a phase II/III confirmatory study designed to evaluate the safety a...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-09-19
Trial ID
NCT01907100
Treatments Being Tested
Tomivosertib combined with pembrolizumab in Subjects with PD-L1 positive NS...
Status
Unknown
Location
Southern Cancer Center
Start Date
2021-06-02
Trial ID
NCT04622007
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of gefitinib...
Status
Completed
Location
Research Site
Start Date
2012-03-15
Trial ID
NCT01544179
Treatments Being Tested
This was a Phase III study of pembrolizumab plus platinum-based doublet che...
Status
Terminated
Location
Pacific Shores Medical Group
Start Date
2018-12-21
Trial ID
NCT03631199
The purpose of this study was to determine if ruxolitinib, in combination w...
Status
Terminated
Location
Multiple Locations
Start Date
2014-02-11
Trial ID
NCT02119650
Treatments Being Tested
This multicenter, randomized, double-blind, placebo-controlled study will e...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01496742
Treatments Being Tested